Cancer and leukemia group B (CALGB) multidrug resistance modulation trials in untreated acute myeloid leukemia
Publication
, Journal Article
Kolitz, JE; George, SL; Baer, MR; Lee, EJ; Bloomfield, CD; Larson, RA
Published in: ANNALS OF HEMATOLOGY
February 1, 2006
Duke Scholars
Published In
ANNALS OF HEMATOLOGY
ISSN
0939-5555
Publication Date
February 1, 2006
Volume
85
Start / End Page
78 / 79
Publisher
SPRINGER
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kolitz, J. E., George, S. L., Baer, M. R., Lee, E. J., Bloomfield, C. D., & Larson, R. A. (2006). Cancer and leukemia group B (CALGB) multidrug resistance modulation trials in untreated acute myeloid leukemia. ANNALS OF HEMATOLOGY, 85, 78–79.
Kolitz, J. E., S. L. George, M. R. Baer, E. J. Lee, C. D. Bloomfield, and R. A. Larson. “Cancer and leukemia group B (CALGB) multidrug resistance modulation trials in untreated acute myeloid leukemia.” ANNALS OF HEMATOLOGY 85 (February 1, 2006): 78–79.
Kolitz JE, George SL, Baer MR, Lee EJ, Bloomfield CD, Larson RA. Cancer and leukemia group B (CALGB) multidrug resistance modulation trials in untreated acute myeloid leukemia. ANNALS OF HEMATOLOGY. 2006 Feb 1;85:78–9.
Kolitz, J. E., et al. “Cancer and leukemia group B (CALGB) multidrug resistance modulation trials in untreated acute myeloid leukemia.” ANNALS OF HEMATOLOGY, vol. 85, SPRINGER, Feb. 2006, pp. 78–79.
Kolitz JE, George SL, Baer MR, Lee EJ, Bloomfield CD, Larson RA. Cancer and leukemia group B (CALGB) multidrug resistance modulation trials in untreated acute myeloid leukemia. ANNALS OF HEMATOLOGY. SPRINGER; 2006 Feb 1;85:78–79.
Published In
ANNALS OF HEMATOLOGY
ISSN
0939-5555
Publication Date
February 1, 2006
Volume
85
Start / End Page
78 / 79
Publisher
SPRINGER
Related Subject Headings
- Immunology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology